225 related articles for article (PubMed ID: 18811673)
1. Seroprevalence of Toxoplasma gondii among Nunavik Inuit (Canada).
Messier V; Lévesque B; Proulx JF; Rochette L; Libman MD; Ward BJ; Serhir B; Couillard M; Ogden NH; Dewailly E; Hubert B; Déry S; Barthe C; Murphy D; Dixon B
Zoonoses Public Health; 2009 May; 56(4):188-97. PubMed ID: 18811673
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of seven zoonotic infections in Nunavik, Quebec (Canada).
Messier V; Lévesque B; Proulx JF; Rochette L; Serhir B; Couillard M; Ward BJ; Libman MD; Dewailly E; Déry S
Zoonoses Public Health; 2012 Mar; 59(2):107-17. PubMed ID: 21824376
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon.
Wam EC; Sama LF; Ali IM; Ebile WA; Aghangu LA; Tume CB
BMC Res Notes; 2016 Aug; 9(1):406. PubMed ID: 27528009
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology associated with the exposure to Toxoplasma gondii in Nunavik's Inuit population using the 2017 Qanuilirpitaa cross-sectional health survey.
Ducrocq J; Ndao M; Yansouni CP; Proulx JF; Mondor M; Hamel D; Lévesque B; De Serres G; Talbot D
Zoonoses Public Health; 2021 Nov; 68(7):803-814. PubMed ID: 34254450
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis.
Minbaeva G; Schweiger A; Bodosheva A; Kuttubaev O; Hehl AB; Tanner I; Ziadinov I; Torgerson PR; Deplazes P
PLoS Negl Trop Dis; 2013; 7(2):e2043. PubMed ID: 23409201
[TBL] [Abstract][Full Text] [Related]
6. Spatial and simultaneous representative seroprevalence of anti-Toxoplasma gondii antibodies in owners and their domiciled dogs in a major city of southern Brazil.
Benitez ADN; Martins FDC; Mareze M; Santos NJR; Ferreira FP; Martins CM; Garcia JL; Mitsuka-Breganó R; Freire RL; Biondo AW; Navarro IT
PLoS One; 2017; 12(7):e0180906. PubMed ID: 28732033
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Toxoplasma gondii in the U.S.: Evidence from a representative cross-sectional survey.
Owusu-Dommey A; Pogreba-Brown K; Villa-Zapata L
Parasitol Int; 2020 Dec; 79():102175. PubMed ID: 32763362
[TBL] [Abstract][Full Text] [Related]
8. Serological and molecular detection of Toxoplasma gondii in terrestrial and marine wildlife harvested for food in Nunavik, Canada.
Bachand N; Ravel A; Leighton P; Stephen C; Ndao M; Avard E; Jenkins E
Parasit Vectors; 2019 Apr; 12(1):155. PubMed ID: 30944016
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence and correlates of Toxoplasma gondii infection in Yoremes (Mayos) in Mexico: a cross-sectional study.
Alvarado-Esquivel C; Rascón-Careaga A; Hernández-Tinoco J; Corella-Madueño MA; Sánchez-Anguiano LF; Aldana-Madrid ML; Almada-Balderrama GJ; Nuñez-Aguirre AD; Liesenfeld O
BMJ Open; 2016 May; 6(5):e010218. PubMed ID: 27173808
[TBL] [Abstract][Full Text] [Related]
10. Toxoplasma gondii seroprevalence in veterinarians in Finland: Older age, living in the countryside, tasting beef during cooking and not doing small animal practice associated with seropositivity.
Siponen AM; Kinnunen PM; Koort J; Kallio-Kokko H; Vapalahti O; Virtala AM; Jokelainen P
Zoonoses Public Health; 2019 Mar; 66(2):207-215. PubMed ID: 30536784
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of toxoplasmosis and risk factors of Toxoplasma gondii infection among pregnant women in Sri Lanka: a cross sectional study.
Iddawela D; Vithana SMP; Ratnayake C
BMC Public Health; 2017 Dec; 17(1):930. PubMed ID: 29202747
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence and associated risk factors of Toxoplasma gondii among Manchu pregnant women in northeastern China.
Jiang RL; Ma LH; Ma ZR; Hou G; Zhao Q; Wu X
Microb Pathog; 2018 Oct; 123():398-401. PubMed ID: 30063975
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiology of Toxoplasma gondii infection in women of child-bearing age in central Ethiopia.
Gebremedhin EZ; Abebe AH; Tessema TS; Tullu KD; Medhin G; Vitale M; Di Marco V; Cox E; Dorny P
BMC Infect Dis; 2013 Feb; 13():101. PubMed ID: 23442946
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence and Risk Factors of
Olariu TR; Ursoniu S; Hotea I; Dumitrascu V; Anastasiu D; Lupu MA
Vector Borne Zoonotic Dis; 2020 Oct; 20(10):763-767. PubMed ID: 32589521
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of anti-
Ekanem US; Moses AE; Abraham EG; Motilewa OO; Umo AN; Uwah AI; Itina EI
Niger J Clin Pract; 2018 Dec; 21(12):1662-1669. PubMed ID: 30560833
[TBL] [Abstract][Full Text] [Related]
16. Serological survey and risk factors associated with
Zakari MM; Isah AY; Offiong R; Yunusa T; Abdullahi IN
Malawi Med J; 2020 Sep; 32(3):160-167. PubMed ID: 33488988
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of Toxoplasma gondii infection in Tepehuanos in Durango, Mexico.
Alvarado-Esquivel C; Estrada-Martínez S; García-López CR; Rojas-Rivera A; Sifuentes-Álvarez A; Liesenfeld O
Vector Borne Zoonotic Dis; 2012 Feb; 12(2):138-42. PubMed ID: 22214274
[TBL] [Abstract][Full Text] [Related]
18. Awareness, knowledge and risk factors of
Eroglu S; Asgin N
J Obstet Gynaecol; 2021 Jul; 41(5):714-720. PubMed ID: 33045851
[No Abstract] [Full Text] [Related]
19. Prevalence and predictors of Toxoplasma gondii infection in pregnant women from Dhamar, Yemen.
Al-Adhroey AH; Mehrass AAO; Al-Shammakh AA; Ali AD; Akabat MYM; Al-Mekhlafi HM
BMC Infect Dis; 2019 Dec; 19(1):1089. PubMed ID: 31888517
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Toxoplasma antibodies among individuals tested at hospitals and private laboratories in Beirut.
Bouhamdan SF; Bitar LK; Saghir HJ; Bayan A; Araj GF
J Med Liban; 2010; 58(1):8-11. PubMed ID: 20358853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
